These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 17197126)

  • 21. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
    Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the "Hostile Pelvis" for Intensity Modulated Radiation Therapy: The Impact of Anatomic Variations in Pelvic Dimensions on Dose Delivered to Target Volumes and Organs at Risk in Patients With High-Risk Prostate Cancer Treated With Whole Pelvic Radiation Therapy.
    Yirmibeşoğlu Erkal E; Karabey S; Karabey A; Hayran M; Erkal HŞ
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):894-903. PubMed ID: 26104941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.
    Cozzi L; Dinshaw KA; Shrivastava SK; Mahantshetty U; Engineer R; Deshpande DD; Jamema SV; Vanetti E; Clivio A; Nicolini G; Fogliata A
    Radiother Oncol; 2008 Nov; 89(2):180-91. PubMed ID: 18692929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.
    Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C
    BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pelvic Ewing sarcomas. Three-dimensional conformal vs. intensity-modulated radiotherapy.
    Mounessi FS; Lehrich P; Haverkamp U; Willich N; Bölling T; Eich HT
    Strahlenther Onkol; 2013 Apr; 189(4):308-14. PubMed ID: 23443613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel conformal arc technique for postoperative whole pelvic radiotherapy for endometrial cancer.
    Yang R; Jiang W; Wang J
    Int J Gynecol Cancer; 2009 Dec; 19(9):1574-9. PubMed ID: 19955940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
    Kam MK; Chau RM; Suen J; Choi PH; Teo PM
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of tomotherapy-based simultaneous integrated boost in whole-pelvis radiation for prostate cancer.
    You SH; Lee JY; Lee CG
    Yonsei Med J; 2015 Mar; 56(2):510-8. PubMed ID: 25684003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
    Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma.
    D'Souza WD; Ahamad AA; Iyer RB; Salehpour MR; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1062-70. PubMed ID: 15752885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer.
    Tao Y; Lefkopoulos D; Ibrahima D; Bridier A; Polizzi Mdel P; Wibault P; De Crevoisier R; Arriagada R; Bourhis J
    Acta Oncol; 2008; 47(3):442-50. PubMed ID: 17906985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
    McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer.
    Nutting CM; Convery DJ; Cosgrove VP; Rowbottom C; Padhani AR; Webb S; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):649-56. PubMed ID: 11020560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy.
    van Lin EN; Hoffmann AL; van Kollenburg P; Leer JW; Visser AG
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):565-76. PubMed ID: 16168848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
    Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
    Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma.
    Forrest J; Presutti J; Davidson M; Hamilton P; Kiss A; Thomas G
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):e63-70. PubMed ID: 21752614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.